GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tandem Diabetes Care Inc (FRA:TD5A) » Definitions » Return-on-Tangible-Asset

Tandem Diabetes Care (FRA:TD5A) Return-on-Tangible-Asset : -18.10% (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Tandem Diabetes Care Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Tandem Diabetes Care's annualized Net Income for the quarter that ended in Mar. 2024 was €-157.2 Mil. Tandem Diabetes Care's average total tangible assets for the quarter that ended in Mar. 2024 was €868.4 Mil. Therefore, Tandem Diabetes Care's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2024 was -18.10%.

The historical rank and industry rank for Tandem Diabetes Care's Return-on-Tangible-Asset or its related term are showing as below:

FRA:TD5A' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -82   Med: -41.32   Max: 1.94
Current: -14.95

During the past 13 years, Tandem Diabetes Care's highest Return-on-Tangible-Asset was 1.94%. The lowest was -82.00%. And the median was -41.32%.

FRA:TD5A's Return-on-Tangible-Asset is ranked worse than
61.2% of 866 companies
in the Medical Devices & Instruments industry
Industry Median: -2.745 vs FRA:TD5A: -14.95

Tandem Diabetes Care Return-on-Tangible-Asset Historical Data

The historical data trend for Tandem Diabetes Care's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tandem Diabetes Care Return-on-Tangible-Asset Chart

Tandem Diabetes Care Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only -9.42 -6.46 2.00 -10.01 -21.94

Tandem Diabetes Care Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -49.22 -14.97 -14.08 -12.56 -18.10

Competitive Comparison of Tandem Diabetes Care's Return-on-Tangible-Asset

For the Medical Devices subindustry, Tandem Diabetes Care's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tandem Diabetes Care's Return-on-Tangible-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tandem Diabetes Care's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Tandem Diabetes Care's Return-on-Tangible-Asset falls into.



Tandem Diabetes Care Return-on-Tangible-Asset Calculation

Tandem Diabetes Care's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=-204.134/( (989.461+871.041)/ 2 )
=-204.134/930.251
=-21.94 %

Tandem Diabetes Care's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=-157.192/( (871.041+865.761)/ 2 )
=-157.192/868.401
=-18.10 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2024) net income data.


Tandem Diabetes Care  (FRA:TD5A) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Tandem Diabetes Care Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Tandem Diabetes Care's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Tandem Diabetes Care (FRA:TD5A) Business Description

Traded in Other Exchanges
Address
11075 Roselle Street, San Diego, CA, USA, 92121
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. Nearly three quarters of total revenue is derived from the U.S., with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.

Tandem Diabetes Care (FRA:TD5A) Headlines

No Headlines